Skip to main content
. 2022 Nov 26;12(12):1756. doi: 10.3390/biom12121756

Figure 3.

Figure 3

Upregulated EIF4G1 in two cohorts, and the results from KM survival analyses. (a,b) Different expression of EIF4G1 between breast cancer tissues and adjacent normal tissues in TCGA cohort and GSE42568; (c) KM survival analysis of high- and low-expression groups in TCGA-training cohort; (d) KM survival curve of the high- and low-expression groups in the meta-validation dataset.